Pharmaceutical and biotech companies

INTRODUCTION

Pharmaceutical and biotech companies are coming under increasing demands to maximize the potential of their asset throughout the entire product lifecycle. This, coupled with growing recognition of the need to provide patient access to medicines for clinical trials and unlicensed and licensed supply, raises multiple challenges at each point of access, spanning the lifecycle from post-trial access to market exit globally.

Health Service is the global leader in the specialist management of ethical, regulatory compliant and efficient solutions to help pharmaceutical and biotech companies provide access to medicines. We are dedicated to delivering the right medicine to the right patient at the right time.

PHARMACEUTICAL AND BIOTECH COMPANIES

Health Service business model, experience and pedigree enable us to effectively operate in a complex global regulatory environment, and ensure that precious medicines are delivered securely and effectively for both pharmaceutical and biotech companies, whenever they are needed, throughout the product lifecycle.

The benefits of enabling access to medicines are significant, not just for patients and healthcare professionals, but also for pharmaceutical and biotechnology companies that invest a huge amount to develop and commercialized these medicines. Health Service’s experience and expertise in providing access across the entire lifecycle of a medicine helps ensure these benefits are realized.

KEY FACTS

HOW CAN WE HELP?

Through Health Services insight, we have a deep understanding of the challenges you face, and our experience enables us to provide effective solutions to help you meet them, adding value at every stage of a product’s lifecycle:

  • Trusted to manage early access to the most promising and innovative new medicines across almost every therapeutic area for both large and small pharmaceutical and biotech companies
  • Experience in providing access to medicines at all stages of the product lifecycle on a global basis
  • Local market knowledge and global regulatory expertise across 130 countries, providing expertise in navigated local requirements and ensuring effective operationalization of programs
  • Supporting pharma companies to move their assets from an unlicensed medicine to a licensed medicine ensuring successful transition and commercial launch
  • Trusted by more than 6000 Healthcare Professionals to provide access to medicines for their patients, and enabling convenient 24/7 access to medicines and information for healthcare professionals through our online portal.

Health Services unparalleled experience and expertise enables pharmaceutical and biotech companies to provide access to innovative medicines to address unmet patient need and maximize the value of your asset. We get medicine.